Global Radiation Dose Management Market: The radiation dose management market is witnessing a significant increase in the market size due to the ongoing COVID-19 pandemic.

Published Date: 03/05/2021

The Global Radiation Dose Management Market was valued at USD 220.22 million by 2020 and is estimated to value over USD 504.11 million by 2027 end with a CAGR of over 5.7% during the forecast period 2020 to 2027.Across the globe, an increasing number of interventional radiology and nuclear medicine procedures are being performed owing to their high imaging efficiency. These procedures use a very high dose of radiation for patients; this, coupled with the longer duration of these procedures, can increase the risk of cancer in patients undergoing these procedures. According to the Society of Nuclear Medicine, around 20 million nuclear medicine procedures are performed every year in the US. As reported by the World Nuclear Association, more than 10,000 hospitals worldwide use radioisotopes in medicine; 90% of the procedures involving radioisotopes are diagnostic. Thus, to cater to the needs of end-users, many players in the market, such as Bayer Healthcare and Sectra Medical Systems, are providing dose management software specifically for RDM in interventional imaging and nuclear medicine. Although CT applications account for a large share of the radiation dose management market, the interventional radiology and nuclear medicine applications are expected to offer significant growth opportunities in the next five years.

There are no defined standards by governments for radiation dose benchmarking across all radiology procedures. With the lack of standardized protocols, dose management software cannot be fully utilized to achieve dose reduction. Since 2011, the American College of Radiology has been trying to set benchmarks for CT procedures at the national level through DIR; however, benchmarking needs to be conducted for all imaging modalities across the globe.

There need to be standardized protocols for all examination types, imaging modalities, and patients of all sizes and age groups, at a global level. The availability of comprehensive benchmarking parameters and defined procedures would enable individual practices to monitor dose indices and compare standard dose reduction practices followed by similar healthcare provider facilities at the regional, state, national, or global levels.